Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Acute Myeloid Leucemia”

6 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 6 of 6 results

Not applicableStudy completedNCT07254611
What this trial is testing

Combination of HMA and Venetoclax With Posaconazole in Patients With Acute Myeloid Leukemia: A Study of Plasma Concentrations

Who this might be right for
AML (Acute Myelogenous Leukemia
Fondazione IRCCS Policlinico San Matteo di Pavia 15
Large-scale testing (Phase 3)Looking for participantsNCT07396480
What this trial is testing

Fludarabine Plus Melphalan Versus Addition of Venetoclax to Fludarabine/Melphalan Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation in AML/MDS Patients Aged > 50 Years: a Multicenter, Randomized, Phase 3 Trial

Who this might be right for
VenentoclaxMyeloid MalignanciesConditioning+3 more
First Affiliated Hospital of Zhejiang University 186
Not applicableStudy completedNCT02714790
What this trial is testing

Prognostic Role of Minimal Residual Disease in Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid LeukemiaMinimal Residual DiseaseWilms Tumor
A.O.U. Città della Salute e della Scienza 281
Not applicableNot Yet RecruitingNCT06906978
What this trial is testing

Single Cell Acute Leukemia Analysis

Who this might be right for
Acute Myeloid Leucemia
Assistance Publique Hopitaux De Marseille 40
Not applicableUnknownNCT01592266
What this trial is testing

F18-FLT PET/CT as a Tool for Assessment of Myeloablative Treatment in Patients With Acute Myeloid Leucemia(AML)

Who this might be right for
Acute Myeloid Leucemia
Hadassah Medical Organization 10
Not applicableNot Yet RecruitingNCT06681363
What this trial is testing

Creation of a Biocollection of Patients With Acute Myeloid Leukemia (AML) or Lymphoid Leukemia (ALL) or High-risk Myelodysplastic Syndrome (MDS) Monitored at the Nantes University Hospital

Who this might be right for
Acute Myeloid LeucemiaHigh-risk Myelodysplastic Syndrome (MDS)Acute Lymphoid Leukemia
Nantes University Hospital 1,000